NDC 50419-254 – Adempas

Riociguat 2.5 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC50419-254

Product details

Brand name
Adempas
Generic name
riociguat
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA204819
Marketed since
October 8, 2013
Listing expires
December 31, 2027
Pharmacologic class
Soluble Guanylate Cyclase Stimulator

Active ingredients

Uses, dosage, side effects and warnings for Adempas →

Package NDC codes (3)

Package NDCDescriptionSince
50419-254-0190 TABLET, FILM COATED in 1 BOTTLE (50419-254-01)Oct 8, 2013
50419-254-032 BLISTER PACK in 1 PACKAGE (50419-254-03) / 21 TABLET, FILM COATED in 1 BLISTER PACKOct 8, 2013
50419-254-919 TABLET, FILM COATED in 1 BOTTLE (50419-254-91)Sep 18, 2014

Other Adempas products